Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dr. Voodoo who wrote (2088)	1/27/1998 9:00:00 PM
From: Cacaito	Read Replies (1) \| Respond to of 7041

Dr. Voodoo, If phentolamine absorption is indeed increase and levels are indeed higher, faster then side effects will logically increase, especially in hypertensive patients (hypotension will be more pronounced in this group and hypotension damage is worst in this group cause their baseline level to keep blood flow is higher) This could trigger a stroke or myocardial infarct or just angina. Of course, the insert package will say please consult your cardiologist first, before pill intake.

To: Dr. Voodoo who wrote (2088)	1/27/1998 9:09:00 PM
From: Dauntless	Read Replies (3) \| Respond to of 7041

Just a thought - Perhaps the reason most of the papers you're finding are by Imhof is he was at Ciba-Geigy & in that time period - say 1970 - 1981 - the patent was still valid & they were the only manufacturer - hence no one else cared. Later, when it came off patent, it had already been replaced by better drugs for its original indication as a vasodilator? Wish I add more - maybe I'll poke around & get back to you. BTW, you wrote: >>Blood levels are an accepted measurement, and a cornerstone for Asensio and Zonagen to make their assertions. My guess originally was that both sides would have data to back up their claims, so far this has been true.<< Where is Asensio's data proving his assertion? The study he quoted used an UNVALIDATED technique. Those results would NEVER be accepted by any trained analytical chemist. The claims made by Asensio in the Jan. 15th report are completely untrue. He reported them for their shock value in a continuing attempt to manipulate the share price. While we argue back & forth here, he gets big time publicity for his lies on PRNewswire & Businesswire. Of course, it works both ways & creates wonderful buying opportunities for knowledgeable investors.